Our research, in line with the proportion of micro-PRLomas in the entire cohort of the Dutch study (8), revealed a lower PRL normalization rate compared to their findings, standing at 60.9%. The gene discussed is PRL; the disease is prolactin-producing pituitary gland adenoma.